Half Year Results 

DCC boosts US healthcare presence

DCC boosts US healthcare presence

DCC (DCC) rounded off a half year laden with acquisitions with the announcement of the $60m (£46.8m) purchase of Ion Laboratories, a Florida-based contract manufacturer of nutritional products. The deal follows a further £118m in acquisition spend over the conglomerate’s first six months, as DCC built out its LPG, energy, retail & oil and healthcare segments over the period.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now